Literature DB >> 12429431

Use of the Plasmodium vivax merozoite surface protein 1 gene sequence analysis in the investigation of an introduced malaria case in Italy.

Carlo Severini1, Michela Menegon, Luigi Gradoni, Giancarlo Majori.   

Abstract

Malaria due to Plasmodium vivax is globally widespread and is associated with substantial morbidity. The parasite was previously prevalent in temperate areas from which it has been eradicated, however there is a risk of re-introduction because of increased international travel and migration. Following the occurrence of an autochthonous case of P. vivax malaria in Italy after decades of malaria eradication, we applied a molecular approach to compare parasites involved in the introduced case and to determine whether a highly polymorphic gene marker could be useful to tag a P. vivax isolate geographically. To this end, the sequence encompassing the interspecies conserved blocks 5 and 6 of the gene encoding for merozoite surface protein 1 (msp-1) was determined in 16 P. vivax isolates from different regions, and analysed along with 24 pvmsp-1 sequences downloaded from published data. Results have shown that: (i). parasites from the introduced case and the putative source of infection identified following epidemiological investigation, although very similar, differed in three nucleotide substitutions, of which one non synonymous; ii). some geographical isolates looked tightly clustered (e.g. Korean and Punjab isolates), but others were less so.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429431     DOI: 10.1016/s0001-706x(02)00186-9

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  6 in total

1.  Using mitochondrial genome sequences to track the origin of imported Plasmodium vivax infections diagnosed in the United States.

Authors:  Priscila T Rodrigues; João Marcelo P Alves; Ana María Santamaria; José E Calzada; Maniphet Xayavong; Monica Parise; Alexandre J da Silva; Marcelo U Ferreira
Journal:  Am J Trop Med Hyg       Date:  2014-03-17       Impact factor: 2.345

2.  Genetic diversity of the malaria vaccine candidate merozoite surface protein 1 gene of Plasmodium vivax field isolates in Republic of Korea.

Authors:  Eun-Taek Han; Yue Wang; Chae Seung Lim; Jun Hwi Cho; Jong-Yil Chai
Journal:  Parasitol Res       Date:  2011-05-10       Impact factor: 2.289

3.  Geographic structure of Plasmodium vivax: microsatellite analysis of parasite populations from Sri Lanka, Myanmar, and Ethiopia.

Authors:  Sharmini Gunawardena; Nadira D Karunaweera; Marcelo U Ferreira; Myatt Phone-Kyaw; Richard J Pollack; Michael Alifrangis; Rupika S Rajakaruna; Flemming Konradsen; Priyanie H Amerasinghe; Mette L Schousboe; Gawrie N L Galappaththy; Rabindra R Abeyasinghe; Daniel L Hartl; Dyann F Wirth
Journal:  Am J Trop Med Hyg       Date:  2010-02       Impact factor: 2.345

4.  Genetic diversity of Plasmodium vivax isolates from Azerbaijan.

Authors:  Marie Claude Leclerc; Michela Menegon; Alexandra Cligny; Jean Louis Noyer; Suleyman Mammadov; Namig Aliyev; Elkhan Gasimov; Giancarlo Majori; Carlo Severini
Journal:  Malar J       Date:  2004-11-09       Impact factor: 2.979

5.  Genetic diversity of msp3alpha and msp1_b5 markers of Plasmodium vivax in French Guiana.

Authors:  Vincent Véron; Eric Legrand; Joséphine Yrinesi; Béatrice Volney; Stéphane Simon; Bernard Carme
Journal:  Malar J       Date:  2009-03-11       Impact factor: 2.979

6.  Implementing parasite genotyping into national surveillance frameworks: feedback from control programmes and researchers in the Asia-Pacific region.

Authors:  Rintis Noviyanti; Olivo Miotto; Alyssa Barry; Jutta Marfurt; Sasha Siegel; Nguyen Thuy-Nhien; Huynh Hong Quang; Nancy Dian Anggraeni; Ferdinand Laihad; Yaobao Liu; Maria Endang Sumiwi; Hidayat Trimarsanto; Farah Coutrier; Nadia Fadila; Najia Ghanchi; Fatema Tuj Johora; Agatha Mia Puspitasari; Livingstone Tavul; Leily Trianty; Retno Ayu Setya Utami; Duoquan Wang; Kesang Wangchuck; Ric N Price; Sarah Auburn
Journal:  Malar J       Date:  2020-07-27       Impact factor: 2.979

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.